Patent Use Code Arguments At Supreme Court Focus On Role Of FDA In Prandin Patent Dispute
This article was originally published in The Pink Sheet Daily
Executive Summary
In oral arguments in Caraco v. Novo Nordisk, justices also ask whether Caraco could have sued FDA for accepting Novo’s Prandin patent use code instead of filing a counterclaim against Novo to force it to change the code.